Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Meeting highlights from the Paediatric Committee: 27 - 29 August 2008 4 september 2008NewsHumanPaediatrics Meeting highlights from the Paediatric Committee: 2 - 4 June 2008 4 september 2008Press releaseHumanPaediatrics Meeting highlights from the Paediatric Committee: 2 - 4 July 2008 4 september 2008Press releaseHumanPaediatrics European Medicines Agency update on progressive multifocal leukoencephalopathy (PML) and Tysabri 13 august 2008Press releaseMedicines Pharmion Ltd withdraws its marketing authorisation application forOrplatna (satraplatin) 4 august 2008Press release Meeting highlights from the Committee for Medicinal Products for Human Use,21-24 July 2008 25 juli 2008Press releaseHuman European Medicines Agency recommends restricting the use of oral moxifloxacin-containing medicines 25 juli 2008Press releaseMedicines Studies assessed by the European Medicines Agency indicate no increased risk of developing cancer for patients who have taken Viracept contaminated with ethyl mesilate 24 juli 2008Press releaseHumanMedicines EMEA recommends restricted use of oral norfloxacin-containing medicines in urinary infections 24 juli 2008Press release Idea AG withdraws its marketing authorisation application for Diractin (ketoprofen) 24 juli 2008Press release 1 … 307 308 309 310 311 Page 311 of 380 312 313 314 315 … 380
Meeting highlights from the Paediatric Committee: 27 - 29 August 2008 4 september 2008NewsHumanPaediatrics
Meeting highlights from the Paediatric Committee: 2 - 4 June 2008 4 september 2008Press releaseHumanPaediatrics
Meeting highlights from the Paediatric Committee: 2 - 4 July 2008 4 september 2008Press releaseHumanPaediatrics
European Medicines Agency update on progressive multifocal leukoencephalopathy (PML) and Tysabri 13 august 2008Press releaseMedicines
Pharmion Ltd withdraws its marketing authorisation application forOrplatna (satraplatin) 4 august 2008Press release
Meeting highlights from the Committee for Medicinal Products for Human Use,21-24 July 2008 25 juli 2008Press releaseHuman
European Medicines Agency recommends restricting the use of oral moxifloxacin-containing medicines 25 juli 2008Press releaseMedicines
Studies assessed by the European Medicines Agency indicate no increased risk of developing cancer for patients who have taken Viracept contaminated with ethyl mesilate 24 juli 2008Press releaseHumanMedicines
EMEA recommends restricted use of oral norfloxacin-containing medicines in urinary infections 24 juli 2008Press release
Idea AG withdraws its marketing authorisation application for Diractin (ketoprofen) 24 juli 2008Press release